Background: The advanced lung cancer inflammation index (ALI) has been reported to predict the overall survival in patients with advanced non-small cell lung cancer (NSCLC). However, no previous studies have examined the prognostic significance of ALI in metastatic NSCLC treated with first line chemotherapy. The objective of this study was to explore the relationship between ALI and the prognosis of metastatic NSCLC treated with first line chemotherapy. Materials and Methods: Data of 109 metastatic NSCLC patients who had completed first line treatment with chemotherapy was collected. A multivariate flexible parametric proportional-hazards model with restricted cubic splines (RCS) was used to explore and identify the independent prognostic factors, including clinical potential factors and ALI for the overall survival. Multivariate regression analysis was used to evaluate the potential prognostic factors associated with short survival less than 6 months. The analysis of the restricted mean survival time (RMST) method was used to estimate the event-free time from zero to 18 months. Results: The median OS was 10.9 months (95%CI 9.57-13.18) and median PFS was 7.5 months (95%CI 6.85-8.00).The multivariate survival analyses revealed two prognostic factors for worse survival: Poor ECOG PS (HR46.90; 95%CI 2.90-758.73; p=0.007) and progressive disease after completing the first line chemotherapy treatment (HR 2.85; 95%CI1.18-6.88; p=0.02),whereas a low ALI
Chantharakhit, C., & Sujaritvanichpong, N. (2021). Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy. Asian Pacific Journal of Cancer Prevention, 22(4), 1149-1156. doi: 10.31557/APJCP.2021.22.4.1149
MLA
Chaichana Chantharakhit; Nantapa Sujaritvanichpong. "Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy". Asian Pacific Journal of Cancer Prevention, 22, 4, 2021, 1149-1156. doi: 10.31557/APJCP.2021.22.4.1149
HARVARD
Chantharakhit, C., Sujaritvanichpong, N. (2021). 'Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy', Asian Pacific Journal of Cancer Prevention, 22(4), pp. 1149-1156. doi: 10.31557/APJCP.2021.22.4.1149
VANCOUVER
Chantharakhit, C., Sujaritvanichpong, N. Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy. Asian Pacific Journal of Cancer Prevention, 2021; 22(4): 1149-1156. doi: 10.31557/APJCP.2021.22.4.1149
)